Pharmacyl AB is a Swedish AB, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 0 employees and reported a gross profit of SEK 364.7k in its latest annual filing.
In its most recent annual report (2024), Pharmacyl AB reported a gross profit of SEK 364.7k. The figures on this page draw on 5 annual filings covering 2019 to 2024. The bottom line showed a net loss of SEK 167.0k, and the EBITDA margin stood at -26.7%.
At the end of 2024, current assets covered short-term debt 0.2 times.
Frequently asked questions
What is the Org number of Pharmacyl AB?
Pharmacyl AB is registered with Bolagsverket / SCB under Org 5591601629.
What is the gross profit of Pharmacyl AB?
Pharmacyl AB reported a gross profit of SEK 364.7k in 2024.
Who is the chairman of Pharmacyl AB?
Per Anders Harald Henriksson chairs the board of Pharmacyl AB, in role since 2025.